TXNIP Links Innate Host Defense Mechanisms to Oxidative Stress and Inflammation in Retinal Muller Glia under Chronic Hyperglycemia: Implications for Diabetic Retinopathy by Devi, Takhellambam S. et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 438238, 19 pages
doi:10.1155/2012/438238
Research Article
TXNIP LinksInnate Host DefenseMechanismsto
Oxidative Stress and Inﬂammation in
RetinalMullerGliaunderChronicHyperglycemia:
ImplicationsforDiabetic Retinopathy
Takhellambam S. Devi,1 Icksoo Lee,2 Maik H¨ uttemann,2
Ashok Kumar,1,3 K wak uD .N antwi, 1 andLalitP.Singh1,3
1Department of Anatomy and Cell Biology, Wayne State University, Detroit, MI 48201, USA
2Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, USA
3Department of Ophthalmology, Wayne State University, Detroit, MI 48201, USA
Correspondence should be addressed to Lalit P. Singh, plsingh@med.wayne.edu
Received 14 July 2011; Accepted 27 November 2011
Academic Editor: Muthuswamy Balasubramanyam
Copyright © 2012 Takhellambam S. Devi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Thioredoxin Interacting Protein (TXNIP) mediates retinal inﬂammation, gliosis, and apoptosis in experimental diabetes. Here,
we investigate the temporal response of Muller glia to high glucose (HG) and TXNIP expression using a rat Muller cell line
(rMC1) in culture. We examined if HG-induced TXNIP expression evokes host defense mechanisms in rMC1 in response to
metabolic abnormalities. HG causes sustained up-regulation of TXNIP (2h to 5 days), ROS generation, ATP depletion, ER
stress, and inﬂammation. Various cellular defense mechanisms are activated by HG: (i) NLRP3 inﬂammasome, (ii) ER stress
response (sXBP1), (iii) hypoxic-like HIF-1α induction, (iv) autophagy/mitophagy, and (v) apoptosis. We also found in vivo that
streptozocin-induced diabetic rats have higher retinal TXNIP and innate immune response gene expression than normal rats.
Knock down of TXNIP by intravitreal siRNA reduces inﬂammation (IL-1β) and gliosis (GFAP) in the diabetic retina. TXNIP
ablation in vitro prevents ROS generation, restores ATP level and autophagic LC3B induction in rMC1. Thus, our results show that
HG sustains TXNIP up-regulation in Muller glia and evokes a program of cellular defense/survival mechanisms that ultimately
leadtooxidativestress,ERstress/inﬂammation,autophagyandapoptosis.TXNIPisapotentialtargettoameliorateblindingocular
complications of diabetic retinopathy.
1.Introduction
Diabetic retinopathy (DR) is the most common cause of
blindness among the working age group people in the US
and around the world. DR has long been considered as a
microvascular disease associated with vessel basement mem-
brane thickening, blood retinal barrier breakdown, capillary
cell death, acellular capillary, neovascularization, and retinal
detachment [1]. However, recent studies have demonstrated
that DR is a neurovascular disease that aﬀects both the
blood vessel and neuroglia [2, 3]. Chronic hyperglycemia-
associated oxidative stress and low-grade inﬂammation are
considered to play critical roles in disease initiation and pro-
gression of diabetic complications including DR [4–6]. Yet,
the molecular mechanisms underlying hyperglycemic injury
and DR pathogenesisarepoorly understood. Various glucose
metabolic defects and abnormal biochemical pathways are
activated in diabetes and under chronic hyperglycemia
[7]. Recently, we demonstrated that thioredoxin interact-
ing/inhibiting protein (TXNIP) is signiﬁcantly increased
both in the diabetic rat retina in vivo and in vitro in retinal
endothelial cells in culture and causes pro-inﬂammatory
gene expression for Cox-2, VEGF-A, ICAM1, RAGE, and
sclerotic ﬁbronectin (FN) [8–10]. Knockdown of TXNIP2 Experimental Diabetes Research
by siRNA in the retina prevents early abnormalities of DR
in streptozocin-induced diabetic rats, which include inﬂam-
mation, ﬁbrosis, gliosis and apoptosis [9, 10].
TXNIP is an early response gene highly induced by
diabetes and hyperglycemia [8, 11, 12]. TXNIP was ini-
tially identiﬁed as one of the proteins that interacts with
thioredoxin (TRX) and blocks its thiol reducing function
[13, 14]. TRX is a 12-kDa protein, which scavenges ROS
and maintains protein cysteine sulfhydryl groups by its
redox-active disulﬁte/dithiol sites. Recent ﬁndings further
demonstrate a potential role for TXNIP in innate immunity
via the NOD-like receptor-NLRP3/caspase-1 inﬂammasome
activation and release of IL-1β in diabetes and oxidative
stress [15, 16]. TXNIP interacts with NLRP3 leading to a
multiprotein NLRP3 complex assembly and autoactivation
of caspase-1. Activated caspase-1 in turn processes pro-
IL-1β to its mature and active form leading to other
pro-inﬂammatory gene induction and inﬂammation [17,
18]. Innate immune receptors TLR4 and RAGE and their
endogenous ligands such as high mobility group binding
protein HMGB1 and S100 calgranulins are reported to be
upregulatedindiabetes[19,20].Currently,NF-κBistheonly
pro-inﬂammatory transcription factor that is implicated in
retinal inﬂammation in diabetes [3, 4, 8, 9] while the role
of other factors is undetermined. Innate immune receptors
signal through activation of NF-κB and AP1 transcription
factorstoinducetheexpressionofvariouspro-inﬂammatory
cytokines and chemokines [4–6].
We recently showed that TXNIP mediates IL-1β expres-
sion in primary Schwann cell in vitro as well as in vivo in
partial sciatic nerve injury [10] by the p38 MAPK/NF-κB
pathway and transcription factor CREB. Similarly, TXNIP
was also shown to be responsible for pro-IL-β expression in
adipocytes by high glucose [21] and HG-mediated NLRP3
inﬂammasome and casapse-1 activation leads to IL-1β mat-
uration [15, 16, 21]. In addition, chronic hyperglycemia may
also evoke other innate host defense/survival mechanisms
such as ER stress/unfolded protein response (UPR) and
hypoxic responses for cell viability in an inﬂamed and
stressful environment [22, 23]. In this regard, chronic
hyperglycemia-associated TXNIP expression could poten-
tially lead to thiol oxidation and misfolded protein accumu-
lation in ER lumen and cause ER stress in diabetes. UPR is a
highlyregulatedintracellularsignalingpathwaythatprevents
aggregation of misfolded proteins. ER stress is known to be
mediated by three UPR branches, namely, the IRE1-XBP1,
PERK-eIF-1α, and ATF6 pathways [22, 23]. These UPR
signals provide an adaptive mechanism for proper protein
folding and processing in the ER and establishment of
tissue homeostasis and cell survival. However, when protein
misfolding is not resolved, the ER stress and UPR trigger
an apoptotic signal to remove demised cells by phagocytes.
Therefore, ER stress may play a critical role in deciphering
cell survival and premature demise in chronic disease and
injury including DR.
Currently, it is recognized that molecular abnormalities
of DR begin early before clinically detectable pathologies
appear in the retina [2–4, 24]. The pathologies once set in
motion are not reversed even after glucose normalization
[25, 26]. Therefore, the detection of molecular abnormalities
andcellularprocessesthatultimatelyleadtolaterpathologies
of DR is of utmost importance in developing therapeu-
tic strategies to prevent blinding ocular complications of
diabetes. Retinal Muller glia, blood vessels, and neuronal
(ganglion) cells interact closely to maintain retinal tissue
homeostasis and cell survival [27]. Muller cells are the
primary glial type in the retina and along with microglia
and astrocytes are considered as resident innate immune
cells. Under stress, they become activated and produce pro-
inﬂammatory cytokines and growth factors to restore tissue
homeostasis [6]. However, in chronic diseases such as DR,
retinal gliosis is prolonged, causing sustained inﬂammation,
cell injury/death, and worsening disease. Nonetheless, a role
forTXNIPinMullergliareactivity,innateimmuneresponse,
ER stress, and inﬂammation under chronic hyperglycemia
and diabetes has not been investigated before. In this
study, ﬁrst, we demonstrate that TXNIP is signiﬁcantly
induced in the diabetic rat retina in vivo and mediates pro-
inﬂammatory IL-1β expression and the induction of radial
glial ﬁbrillary acidic protein (GFAP) indicating Muller cell
activation. Secondly, we show that chronic hyperglycemia
sustains TXNIP up-regulation in Muller glia in in vitro
culture and orchestrates a temporal program of innate host
defense mechanisms that lead to cellular oxidative stress,
ER stress, inﬂammation, and autophagy/apoptosis. These
ﬁndings provide important insights as to how retinal Muller
glia might respond to chronic hyperglycemia in diabetes and
that TXNIP may play a critical role in glial dysfunction and
disease progression in DR.
2.MaterialsandMethods
2.1. Materials. Tissue culture media, serum and antibiotics
were purchased from Invitrogen (Carlsbad, CA). Antibod-
ies for TXNIP and beclin 1 were obtained from MBL
(Woburn, MA). Anti-S-Nitroso-Cysteine (SNO-Cys) anti-
body was from Sigma-Aldrich (St. Louis, MO). The LC3B
antibody kit for autophagy (Cat number L10382), Mito-
TrackerRedCMXROS(M7512),ROSdetectionreagentCM-
H2DCFDA(C6827),andATPassaykitswerefromMolecular
Probes (Invitrogen). Antibodies for pro-IL-1β, pro-caspase-
1, NLRP3 (cryopyrin), and HMGB1 are from Santa Cruz
Biotechnology (Santa Cruz, CA), and VDUP1 (TXNIP),
tubulin, and Actin were from Abcam (Cambridge, MA).
Anti-p65 NF-κB and phospho-p65 NF-κB antibodies were
from Millipore (Invitrogen). Electrophoresis Mobility Shift
Assay(EMSA)kitforTranscriptionfactorsXBP1andHIF-1α
to consensus DNA was custom-made by Signosis Inc. (Sun-
nyvale, CA). Fluorescent-labeled secondary antibodies anti-
rabbit and anti-mouse were obtained from Molecular Probes
while those of the anti-goat antibodies were purchased from
Abcam (Cambridge, MA). Active caspase-1 (Green FLICA
Caspase-1)andCaspase-3(GreenFLICAcaspase-3&7)were
purchased from Immunochemistry Technologies (Bloom-
ington, MN). Predesigned TXNIP siRNAs were purchased
from Qiagen (SABiociences). TRIZOL for RNA isolation
was from Invitrogen and PCR primers were also synthesized
by Invitrogen or Applied Biosystems. First strand cDNAExperimental Diabetes Research 3
synthesis kit and SYBR green reagents were purchased from
Biorad as well as from Applied Biosystems. Primer sequences
are available upon request.
2.2. Diabetes Induction of Rats. Diabetes of adult male
Sprague-Dawley rats (∼275g) was induced by intraperi-
toneal injection of a single dose of streptozotocin, (STZ,
65mg/kg body weight, Sigma) dissolved in 0.01M citrate
buﬀer, pH 4.5 as described recently [8, 9]. The rats were
treated in accordance with the principles of NIH guidelines
for the Care and Use of Laboratory Animals and approved
by the Institutional Animal Care and Use Committee.
Intravitreal injection of siRNA targeted to rat TXNIP
promoter (transcriptional gene silencing, RNAi TGS) has
been described before [9] and performed in anaesthetized
rats with 40 mg/kg body weight (pentobarbital) on the right
eyes of diabetic rats (Treatment) and a similar volume of
scramble-RNA on the left eye (Control). The injections were
performed twice at day 23 and 27 and they were sacriﬁced
at day 30. An overdose of pentobarbital (200mg/kg weight)
was given to euthanize the rats. The retina were removed,
processed for immunohistological analysis or frozen imme-
diately in liquid N2, and stored at –80◦C until used.
2.3. Cell Culture. We used a well-established rat retinal
Muller cell line (rMC1) [28]. rMC1 cells were cultured in
medium containing DMEM (low glucose, 5.5mM) and
Ham’s F-12 (3:1 ratio) supplemented with 5.0% fetal
calf serum (FCS) and 0.5mg/mL gentamicin at 37◦Ci n
a humidiﬁed chamber with a 5% CO2–95% air mixture
[9, 29]. Cells at 70–80% conﬂuence were replaced with
low serum overnight (0.2% serum medium). For the time
course, HG (high glucose, 25mM) with 24h treatment
was added ﬁrst; then on the second day HG was added
at 4, 2h, and 0 (no addition) to respective cultures before
harvesting. Thus, all cells maintain a similar condition and
length of serum-deprivation during the entire experimental
procedure. Similarly, for long-term cultures also, HG was
added ﬁrst to the 5-day culture, then after two days for 3
days, 1 day, and 0 before harvesting. Media were changed
every 48h. Cells were harvested by scrapping, snap frozen
a n ds t o r e da t−80◦C until used.
2.4.SDS-PAGEandWesternBlotting. Proteinswereextracted
in RIPA buﬀer containing protease inhibitors and their
concentrations were determined using a Coomassie Plus
(Bradford) Assay Reagent from Pierce (Product number
23238) with BSA as the standard. Absorbance of blue dye
of the Coomassie-protein complex was measured at 595nm
using a Gemini Microplate reader (Molecular Devices,
Sunnyvale, CA). Thirty micrograms of protein extracts was
subjected to sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDA-PAGE) and Western blot analysis of
proteins was performed as described previously [30]. Santa
Cruz antibodies were used at 1:200 dilutions while anti-
bodies from other sources were diluted at 1:1000 dilutions.
Secondary antibodies were used at 1:3000 dilutions. ECL
used to detect the immunoreactive bands.
2.5. Real-Time Quantitative PCR. Total RNAs were isolated
byTRIZOLmethodandﬁrst-strandcDNAs(from1μgRN A)
were synthesized in 20μL volume using the Bio-Rad iScript
cDNA synthesis kit [8, 12]. Messenger RNA expression was
analyzed by real-time quantitative PCR using the Bio-Rad
Chromo 4 detection system and SYBR Green PCR Master
Mix from Bio-Rad or Applied Biosystems (Foster City, CA).
Primers were designed using Primer Express v 2.0 (Applied
Biosystems) and synthesized by Invitrogen (Carlsbad, CA).
Primers for the real-time Q-PCR will be available upon
request.
The real-time PCR reaction mixture contained 1X
SYBR Green PCR Master Mix, 400nM forward and reverse
primers, and 2μLc D N Ai naﬁ n a lv o l u m eo f2 5μL. The PCR
cycling was programmed as 95◦C for 15s, 55◦Cf o r3 0sa n d
72◦C for 30s 40 cycles followed by the construction of a
meltingcurvethroughincreasingthetemperaturefrom60◦C
to 95◦C at a ramp rate of 2% for 20min. The real-time PCR
samples were evaluated using a single predominant peak as a
quality control. Ct values were used to calculate the relative
expression level of mRNAs that were normalized to actin
[8, 12].
2.6. Determination of Cell Viability. We used MTT assay
to measure cell viability at diﬀerent time periods after HG
addition. MTT assay for cell viability was performed in
48 well plates and with 0.5mg/mLMTT in each well as
previously described in our laboratory [31, 32]. rMC1 cells
(1 × 104 cells) were grown to 70% conﬂuence and serum-
starved overnight and treated with HG. MTT was added for
3h at the end of the experiment, the media was removed,
and cells were kept in 100μLo fD M S Of o r1 0m i n u t e s .
The resulting color was diluted with 500μL of distilled H2O
and detected at 570nm using a Gemini Microplate reader
(Molecular Devices, Sunnyvale, CA).
2.7. Intracellular Reactive Oxygen Species (ROS) Measure-
ment. The formation of intracellular ROS in rMC1 cells was
detected as described before [8, 12] by using the ﬂuorescent
probe, 5-(and-6)-chloromethyl-2 ,7 -dichlorodihydroﬂuo-
rescein diacetate, acetyl ester (CM-H2DCFDA). This dye
can enter living cells by passive diﬀusion it is nonﬂuorescent
until the acetate group is cleaved oﬀ by intracellular
esterase, and oxidation occurs within the cell. Approximately
1 × 105 cells/mL were cultured in 24 well plates, serum-
starved overnight, and glucose was added for the speciﬁed
time period. Then, CM-H2DCFDA (10μM) was incubated
for 60min at 37◦C. The medium with the dye is aspirated
(to remove the extracellular dye), washed with PBS (3x),
and then the PBS is added to cells. The ﬂuorescence was
measured in a Gemini Fluorescent Microplate Reader
(Molecular Devices) with the bottom read scanning mode at
480nm excitation and emission at 530nm.
2.8. Immunohistochemistry (IHC)
(i) Retinal Tissue. Immunohistology of retinal sections was
similar to those described recently [9]. The retinas were ﬁxed4 Experimental Diabetes Research
in the eyecups with 4% paraformaldehyde in 0.1M phos-
phate buﬀer (PB) for 20min. The retinas were cryoprotected
in a sucrose gradient (10%, 20%, and 30% w/v in PB, resp.).
Cryostat sections were cut at 16μm in Tissue Tek (OCT
mounting medium). Retinal sections were blocked for 1h in
a PB solution that contained 5% Chemiblocker (Chemicon,
Temecula,CA),0.5%TritonX-100,and0.05%sodiumazide.
The primary antibodies were diluted in the same solution
(1:100 to 1:200 dilution depending on the antibody) and
applied overnight at 4◦C followed by appropriate secondary
antibodies (1:600 dilutions) conjugated with Alexa Fluor
488 or Alexa Fluor 594 for 2 hours at room temperature.
After washing with PB again, rMC1 cells were mounted with
an aqueous mounting medium with anti-fade agent with
D A P Ia n ds e a l e dw i t hn a i lp o l i s h .T h ei m a g e sw e r ec a p t u r e d
by an OLYMPUS BX 51 ﬂuorescence microscope, which is
ﬁtted with a triple DAPI/FITC/TRITC cube, a DP70 digital
camera, and image acquisition software. Some images were
also captured with a Zeiss Apotome microscope with Z-
section (Zeiss, Oberkochen, Germany). Similar magniﬁca-
tion (400x) and exposure time were maintained throughout
for comparing images unless otherwise mentioned.
(ii) rMC1 Cells. Cells were grown either in four-chambered
tissue culture glass slides (NUNC, Naperville, IL) and
e x p o s e dt oH Gf o r5d a y sa sd e s c r i b e d[ 32]. Cells were ﬁxed
with freshly prepared paraformaldehyde (4%) for 2h in ice
or 4◦C overnight, washed 10min each with PB (3 times),
and blocked with 5% horse serum in PB for 1h at room
temperature. Following a 30-minute wash with PBS, cells
were incubated with primary antibodies (1:100 dilutions)
overnight at 4◦C in a humidiﬁed chamber. After washing
with PB, cells were further incubated with corresponding
secondary antibodies conjugated with Alexa Fluor 488 or
Alexa 594 at 1:500 dilutions for 1h at 37◦Ci nad a r k e n e d
humidiﬁed chamber. The cell-associated ﬂuorescence was
observed in Olympus BX51 ﬂuorescence microscope.
2.9. Cytochrome c Oxidase and ATP Assays. The mitochon-
drial oxidative phosphorylation (OxPhos) process consists of
the electron transport chain (ETC) and ATP synthase, and
it provides more than 90% of cellular energy. The terminal
enzymeofETCiscytochromec oxidase(CcO).CcOtransfers
electrons from cytochrome c to oxygen, which is reduced
to water. In intact mammalian cells, this reaction is the
proposed rate-limiting step of the ETC under physiological
conditions [33]. Therefore, CcO is an ideal marker enzyme
of OxPhos and was analysed in this study.
(i) CcO Activity. The oxygen consuming capacity of CcO-
analyzed in a closed chamber equipped with a micro-
Clark-type oxygen electrode (Oxygraph system, Hansatech,
Norfolk, England) as previously described [34, 35]. Brieﬂy,
frozen cells were solubilized in 10mM K-HEPES (pH 7.4),
40 mM KCl, 1% Tween 20, 1μM oligomycin, 1mMPMSF,
1 0m MK F ,2m ME G T A ,a n d1m MN av a n a d a t e .C c Oa c t i v -
ity was measured in the presence of 20mM ascorbate and by
addition of increasing amounts of cow heart cytochrome c.
Oxygen consumption was recorded on a computer and ana-
lyzed withthe Oxygraphsoftware.Protein concentration was
determined with the DC protein assay kit (Bio-rad). CcO-
speciﬁc activity is deﬁned as consumed O2 (μM)/min/mg
total protein.
(ii) ATP Assay. Determination of ATP levels using the bio-
luminescent method was performed as described previously
[34, 35]. ATP was released from rMC1 cells maintained in
24 well plates using the boiling method. Two hundred ﬁfty
μlT Eb u ﬀer (50mM Tris-Cl, pH 7.4, 4mM EDTA) was
added to the wells and scrapped oﬀ. Cells were immediately
transferred to a boiling water bath for 4min. Samples
were put on ice and sonicated brieﬂy and centrifuged. ATP
concentration was determined in the supernatant with an
ATP bioluminescence assay kit (Invitrogen) according to the
manufacturer’s manual. Relative ﬂuorescence units (RLUs)
were detected in a Luminometer (Promega, Madison, WI).
Experimentswereperformedintriplicatesforeachcondition
and data were standardized to the protein concentration
using the Biorad protein assay kit.
2.10. Gel-Shift Assay. The gel-shift or electrophoretic
mobility-shift assay (EMSA) provides a simple and rapid
method for detecting DNA-binding activity of proteins. We
investigated the sXBP1 and HIF-1α activity of rMC1 nuclear
proteins by using a commercially available gel-shift assay kit
from Signosis (Sunnyvale, CA) according to manufacturer’s
instructions and as described before [32]. After incubation
at 16◦C for 30min with biotin-labeled probes and nuclear
extracts (5.0μg protein) in a PCR machine, the protein-
DNA complexes were subjected to 6.5% nondenaturing
polyacrylamide gels prepared with TBE gel formulation [32].
The gels were run at 100V for 1h until the Bromophenol
blue dye front is three quarters down the gel, using 0.5x TBE
running buﬀe r .F o rc o m p e t i t i v ea s s a y s ,e x c e s sc o l dp r o b e s
were added to the reaction. Streptavin-HRP and ECL were
used to detect and capture the reactive bands using a Cell
Bioscience FluorChem E System (Santa Clara, CA).
2.11. Statistical Analysis. Results are expressed as means
+/− SE. Student’s t-test or one-way ANOVA followed by
Bonferroni Post Hoc Test was used to compare diﬀerences
between treatment conditions [8, 9]. A preset P value of
<0.05 was considered statistically signiﬁcant.
3. Results
3.1. Diabetes Induces TXNIP Expression, Muller Glia Reactiv-
ity, and Proinﬂammatory Gene Expression in the Rat Retina.
We have recently shown that TXNIP expression is increased
in the retina of STZ-induced diabetic rats at both 4 and 8
weeksofdiabetesduration[8,9]andmediatesinﬂammation,
gliosis/ﬁbrosis, and apoptosis of retinal cells. In this study,
we further support our previous ﬁndings by showing that
the expressions of TXNIP, pro-inﬂammatory IL-1β,i N O S ,
and pattern recognition receptors TLR4 and P2X7R in the
retina are elevated at 4 weeks of diabetes (Figure 1(a)).Experimental Diabetes Research 5
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Figure 1: Diabetes induces TXNIP and pro-inﬂammatory gene expression and glia reactivity in the rat retina. (a) Messenger mRNA levels
for TXNIP (4.55-fold ± 0.96) and pro-inﬂammatory IL-1β (9.19±4.62), iNOS (2.22 ± 0.76), and pattern recognition receptors TLR4 (4.04
± 1.43) and P2X7R (3.26 ± 0.73) are increased signiﬁcantly (P<0.05, n = 6) in the retina of diabetic rats (4 weeks) when compared with
the normal retina. GS is marginally increased (1.55 ± 0.29) but not signiﬁcant (P = 0.3). (b) GFAP staining, a marker of gliosis, is also
increased radially throughout the neuroretina in the diabetic rat versus the normal retina, suggesting Muller glia activation. GCL: ganglion
cell layer; INL: inner nuclear layer; and ONL: outer nuclear layer. (c–e) TXNIP knockdown by siRNA targeted to the promoter (RNAi TGS,
[9]) reduces IL-1β and GFAP mRNA levels in the diabetic retina as compared to the scr-siRNA-treated diabetic rat retina. Under these
conditions (4 weeks of diabetes induction in rats), we did not see an increase in retinal TNF-α mRNA level.
On IHC, we observed that the increased pro-inﬂammatory
gene expression is associated with enhanced GFAP staining,
a marker for glia activation, in the entire length of the
neural retina from diabetic rats when compared with the
nondiabetic normal rat retina (Figure 1(b)). Speciﬁcally, in
the normal rat retina, GFAP staining is restricted to the inner
limiting membrane of Muller glia end-feet and ganglion
cell layer (GCL), however, in the diabetic rat retina, GFAP
ﬁlaments extend from GCL to inner nuclear (INL), outer
nuclear layer (ONL), and the inner and outer plexiform
layers suggesting retinal injury and inﬂammation. Knock-
down of TXNIP by intravitreal injection of promoter-
targeted siRNA (RNAi TGS) further reduces IL-1β and
GFAP up-regulation signiﬁcantly (P<0.05, n = 6) in6 Experimental Diabetes Research
the diabetic rat retina (Figures 1(c) and 1(e)). Under these
conditions, we did not observe an enhancement of TNF-
α, another pro-inﬂammatory cytokine, in the diabetic retina
(Figure 1(d)). TNF-α has previously been shown to induce
at early at 1-2 weeks of STZ-induced diabetic rat retinas
and then suppresses until late stages of diabetes duration
where it may play a critical role in retinal inﬂammation and
BRB breakdown [26]. Thus, the results demonstrate that
there is an early inﬂammatory response and gliosis in the
diabetic retina. Retinal Muller glia forms a close association
with neuron and blood vessel and plays a critical function
in maintaining retinal homeostasis in health and disease.
Therefore, we propose that Muller glia reacts to retinal
injury both in retinal vessels and neurons in diabetes and
produces pro-inﬂammatory and survival factors to restore
tissue homeostasis.
3.2. HG Induces TXNIP Expression and Innate Immune
Responses in rMC1 in Culture. We have shown previously
that TXNIP expression and Muller glia activation occur
early in the diabetic retina [9]. So far, a role for TXNIP in
Muller cell activation and pro-inﬂammatory gene induction
under HG exposure has not been investigated. Therefore, we
undertook a series of experiments to examine the temporal
response of rMC1 to chronic hyperglycemia in culture. We
show that HG exposure in rMC1 induces a signiﬁcant (P<
0.05, n = 6) increase in TXNIP mRNA expression (2–24h)
when compared with low glucose (5.5mM, LG) indicated as
time 0 control (Figure 2(a)). We have previously shown that
TXNIP mediates pro-IL-1β expression in primary Schwann
Cells via the NF-κB-dependent pathway [10]. Therefore, we
examined if TXNIP expression correlates with pro-IL-1β
induction in rMC1 under HG. As shown in Figure 2(b),H G
increases IL-1β mRNA expression at 2 and 4h (P<0.01)
and then reduces at 24h to the level of the control at 0
time. Furthermore, nuclear NF-κB level is also enhanced by
HG in rMC1 from 2 to 24h (Figure 2(c)), which correlates
with activation of caspase-1 in rMC1 (Figure 2(d)). Active
caspase 1 is responsible for processing pro-IL-1β (34-kDa) to
an active mature form of IL-1β (17-kDa).
We further examine whether the protein levels of TXNIP
and pro-IL-1β protein are induced by HG and if the levels
of NLRP3 and caspase-1 are important for processing pro-
IL-1β to its mature form in a time-dependent manner.
TXNIP expression is low in rMC1 under LG while HG
upregulates TXNIP (∼4-folds) signiﬁcantly from 2h to 5
days (Figures 3(a) and 3(c)). Nuclear level of phosphorylated
p65 subunit of NF-κB increases at 2 and 4h but reduces at
24h(Figure3(b));however,itelevatesagainatday2through
day 5 (Figure 3(d)). Pro-IL-1β is also increased at 2 and 4h
of HG exposure and reduces at 24h, and again induces at
3 days of HG (Figures 3(c) and 3(d)), which correlates with
NLRP3 expression. Procaspase 1 level is lower at 2 and 4h
and upregulated at 24h (Figure 3(c)). This is in agreement
with the increased level of active caspase-1 at 24h shown
in Figure 2(d). Pro-caspase-1 level rises again at 5 days of
HG exposure (Figure 3(d)). The results demonstrate that
TXNIP is a glucose-sensitive gene and its expression remains
upregulated when hyperglycemia persists. On the other
hand, the innate immune response to chronic hyperglycemia
by IL-1β, NLRP3 and caspase-1 inﬂammasome is cyclical.
3.3. Chronic Hyperglycemia Induces ROS Generation and
Reduces Cellular ATP in rMC1. We have observed previously
that HG sustains TXNIP and induces IL-1β expression.
TXNIP is a pro-oxidative stress protein through its inter-
action/inhibition of the thiol reducing activity and ROS
scavenging capacity of TRX. In addition, extracellular ATP
release has been shown to involve in NLRP3 inﬂammasome
assembly, and IL-1β processing. Therefore, we examined a
time-dependent generation of intracellular ROS and ATP as
wellasextracellularATPreleaseinrMC1uponHGexposure.
HG signiﬁcantly reduces ROS levels early at 4 and 24h (P<
0.05 versus LG, n = 6) and then rises at day 2 though not
signiﬁcant (Figure 4(a)). However, at day 3 of HG exposure,
rMC1 cells produce signiﬁcantly higher levels of ROS (P<
0.05, n = 6) than LG and sustain up to day 5.
Excess nutrient (glucose availability) could enhance
glucose metabolic ﬂux through glycolysis and mitochondrial
OxPhos via the electron transport chain (ETC) and ATP
production. Therefore, we measured temporal changes in
intracellular ATP levels in rMC1 after HG exposure. As
shown in Figure 4(b), the intracellular ATP concentration
is signiﬁcantly (P<0.05, n = 4) enhanced at 4h and
reduces at 24h when compared with time 0 control. The
reduction in ATP persists at day 2 through 5 (P<0.01 versus
time 0 control, n = 3). At day 3 and 5 of HG, the level of
ATP is further reduced to ∼65% of the control ATP level
at LG (Figure 4(c)). In case of the extracellular ATP level,
there is a small but signiﬁcant increase at 4 and 6h and
then at day 1 onwards their levels are reduced though not
signiﬁcant (unpublished data). These results indicate that
an initial increase in ATP generation via the mitochondrial
OxPhos may result in ROS generation. Initially, this may
induceanantioxidantresponseleadingtoareductioninROS
level. However, as hyperglycemia persists, ROS overwhelms
the anti-oxidant capacity.
3.4. Mitochondrial Electron Transport Chain (ETC) Protein
Cytochrome c Oxidase Activity (CcO) and MTT Cell Viability
Are Maintained under HG. As described previously, ROS
generation and ATP reduction occur in rMC1 cells under
chronic HG. Therefore, the mitochondrial ETC function,
especially the oxygen consumption capacity of CcO activity
at Complex IV, may be reduced. We measure the O2
consuming capacity of CcO in an in vitro assay using a
closed oxygen chamber. In contrast to our prediction, the
CcO activity is unaﬀected by chronic HG exposure of rMC1
(Figures 5(a) and 5(b)). In addition, we did not observe
an initial sigmoidal rate of the CcO activity using diﬀerent
protein concentrationsof cytochrome c in the O2 consuming
assay, indicating that, under these experimental conditions,
CcO may not be regulated by posttranslational modiﬁcation
as previously described [34].
We next examined whether cell viability is reduced by
ROS and ATP in rMC1 cells using MTT assay. An increase
in MTT absorbance measures the reductase activity of
mitochondrial succinate dehydrogenase at complex II, whichExperimental Diabetes Research 7
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Figure 2: HG induces TXNIP expression and evokes the host innate immune response in rat Muller glia. Quantitative RT-PCR for (a)
TXNIP and (b) IL-1β mRNA expression in rMC1 is shown. HG increases TXNIP mRNA at 2–24h (P<0.05 versus time 0, n = 6) while
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is frequently used to monitor cell viability. As shown in
Figure 5(c), MTT activity is not aﬀected by HG exposure
up to 2 days and increases at day 3 through 5 (P<0.01,
n = 6). These results suggest that rMC1 maintains a func-
tional mitochondria and viability in spite of the ROS
generation and ATP depletion. To further ascertain that HG
maintains rMC1 viability under increased ROS, ATP release,
and IL-1β expression, we treated rMC1 cells with exogenous
H2O2 (0.2mM), ATP (0.1mM), and IL-1β (10ng/mL) with
or without HG. We observed that H2O2,A T P ,a n dI L - 1 β
increase ROS levels signiﬁcantly (P<0.05, n = 6) at 4 to
96h and reduce cell viability as indicated by reduced MTT
levels under LG at 48h (unpublished data). However, when
HG is added, the eﬀect of H2O2,A T P ,a n dI L - 1 β on MTT
activity is nulliﬁed. This occurs even when HG increases
the generation ROS further with H2O2,A T P ,o rI L - 1 β in
combination. Therefore, these ﬁndings suggest that rMC1
activates a cellular defense and survival mechanism(s) under
HG and oxidative stress, and TXNIP may play a role in this
process.
3.5. HG Increases Autophagy/Mitophagy, Inﬂammation, and
Apoptosis in rMC1 Cells. We observed that HG increases
TXNIP expression and ROS generation and sustained ATP
reduction in rMC1 cells. Nonetheless, the mitochondrial
CcO enzyme activity and cell viability are maintained.8 Experimental Diabetes Research
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Therefore, we hypothesize that a cell survival program is
evoked under chronic hyperglycemia and oxidative stress
in rMC1. Excess ROS production causes protein misfold-
ing/aggregation and organelle damage (e.g., mitochondria).
Autophagy is a cellular survival mechanism for long-lived
fully diﬀerentiated cells and for phagocytes under cellular
stress to remove damage organelles and their regeneration
[36, 37]. Beclin 1 is an autophagy initiating protein that
interacts with prosurvival bcl2 and bcl-xL [38]. Under
oxidative stress, beclin 1 is released from bcl2 and activates
theautophagicprocess,whichfurtheractivatesthelatephage
autophagosome marker, light chain LC3B [39]. Therefore,
we examined beclin 1 expression in rMC1 under chronic
hyperglycemiaatday3and5.AsshowninFigure6(a),beclin
1 staining is marginally increased in rMC1 under HG than in
LG, however there are more beclin 1 punctae in the cytosol
and over the nuclei suggesting activation of an autophagic
process. This beclin 1 puncta is not seen up to day 3 (not
shown).
Next, we used a mitochondrial staining dye, MitoTracker
red,toexaminethemitochondrialmorphology.Weobserved
an enhanced mitochondrial staining as well as the formation
of larger mitotracker puncta (Figure 6(c)), indicating that
autophagy/mitophagy may occur in rMC1 under chronic
hyperglycemia. Subsequently, using an autophagy assay kit
for LC3B staining, we show that HG increases the numberExperimental Diabetes Research 9
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and size of LC3B puncta formation (LC3BII, active form) in
rMC1 when compared with LG (Figure 6(d)). Smaller LC3B
p u n c t a ea r ea l s op r e s e n ti nr M C 1a f t e r5d a y so fL Gu n d e r
low serum medium. In addition, we observed that at 8 weeks
of diabetes, formation of LG3B puncta occurs in the retina
and they colocalize with TXNIP (unpublished data).
The mechanism of autophagy/mitophagy initiation
under chronic hyperglycemia, TXNIP, and ROS is not fully
understood at the present time. However, the thiol oxidation
of the nuclear high mobility group box protein 1 (HMGB1)
under oxidative stress has been implicated in its nuclear
export and cytosolic interaction with beclin 1 to release from
bcl2andtoinitiate anautophagicprocess[39].Therefore,we
examined levels of TXNIP and HMGB1 in the nucleus and
cytosol. We observed that TXNIP expression in the nucleus
is also increased in rMC1 under HG (unpublished data) in
addition to their cytosolic expression as observed in Figure 3.
HMGB1levels,bothinthenucleusandinthecytosol,arenot
alteredat0–24hbutdecreaseatday2and3inthecytosoland
then increase again at day 5. Furthermore, we observed that
protein cysteine (thiol) nitrosylation (SNO) is enhanced in
HG as measured by an anti-SNO antibody on IHC, and SNO
colocalizes with HMGB1 (unpublished data). In addition,
beclin 1 and HMGB1 colocalize in the cytosol. These results
show that autophagy/mitophagy is activated in rMC1 under
HG and that beclin 1 and oxidized HMGB1 may play a role
in initiating the process.
Autophagy/mitophagy is initially a mechanism for cell
survival; however excessive and continuous autophagy may
remove vital proteins and organelles and induce cell apop-
tosis [36, 37]. Therefore, we examined whether proapoptotic
caspase-3 is activated under chronic HG in rMC1. As shown
in Figures 7(a) and 7(b), HG increases TXNIP and caspase-
3 staining in rMC1 when compared with LG, suggesting10 Experimental Diabetes Research
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Figure 5: HG eﬀects on mitochondrial electron transport chain (ETC) enzyme activity in rMC1. (a-b) Cytochrome c oxidase (CcO) activity
was determined by increasing the amount of substrate cytochrome c in a polarographic method as described in Methods. CoO activity is
deﬁned as consumed O2 [μM]/min/protein [mg]. Oxidative metabolism was increased after incubation in high glucose medium as was seen
by an incremental increase of CcO activity at 24h as well as at 3 and 5 day by ∼12%. Shown are representative experiments (n = 3; standard
deviation <4% at maximal turnover). (c) MTT Assay for rMC1 cell viability was measured in 48-well cultures at various time periods of
hyperglycemia exposure. MTT activity was not signiﬁcantly altered up to 2 days; however at day 3 to 5, there is a signiﬁcant (P<0.01, n =
6–8) increase versus LG (time 0 control).
cells undergoing a path of apoptotic cell death. Furthermore,
injured and dying cells induce the expression of pro-
inﬂammatory genes signiﬁcantly (P<0.05) for TXNIP
(∼36.55 ± 12.45 at day 3), iNOS (14.47 ± 4.8 at day 3), Cox-
2 (4.49 ± 0.88 at day 5) and VEGF-A mRNA (2.15 ±
0.27 day 5) (Figures 7(c)–7(f)). These results suggest that
under HG and oxidative stress, rMC1 cells promote an
inﬂammatoryandautophagy/mitophagyresponsetoremove
defective organelles.
3.6. HG Evokes an Early ER Stress and a Later Hypoxic-Like
Response in rMC1. As shown above in Figure 3, TXNIP
upregulation is sustained in rMC1 cells under conditions of
HG. TXNIP is a pro-oxidant and pro-inﬂammatory protein
[8, 12]. However, we observed at 4 and 24h after HG
exposure in rMC1 that TXNIP up-regulation is associated in
factwithasigniﬁcantdecreaseinROSlevel(Figures3and4).
Therefore, we hypothesized that the early induction of ATP
generationinrMC1byHG(Figure4(b))mightinduceamild
increase in mitochondrial ROS (and possibly an increase
in protein synthesis) that could potentially cause an ER
stress and unfolded protein response, such as the IRE1/XBP1
branch. Spliced form sXBP1 (an active transcription factor)
of XBP1 mRNA is translated and translocated to the nucleus
where it induces the expression of antioxidant genes (e.g.,
superoxidedismutasesandcatalase)[22,23].Indeed,expres-
sion of SOD1 and catalase eﬀectively increases the cellular
antioxidant capacity [40]. Therefore, we examined levels of
sXBP1 mRNA. We did not observe a signiﬁcant alteration
in sXBP1 mRNA in HG when compared with LG although
there is an increasing trend at 4h (Figures 8(a) and 8(b)).
However, the DNA-binding activity of the nuclear sXBP1 is
increased in EMSA (Figure 8(c)) at 4 and 24h by HG and
reduces at day 3 and 5. These results suggest that there is
an early ER stress response in rMC1 under HG, which may
eﬀectively scavenge ROS (Figure 4(a)). However, as the ROSExperimental Diabetes Research 11
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Figure 6: HG activates autophagy/mitophagy in rMC1. Cells were grown in HG for 5 days under low serum conditions in a four-well slide
chamber with media changing for every 48h and 24h for the ﬁnal day. Cells were ﬁxed and stained for (a) beclin 1 antibody and (b) a
na¨ ıve IgG for control antibody reaction. There are more beclin 1 puncta in HG than in LG. (c) MitoTracker Red staining also reveals more
mitochondrial puncta in HG than in LG. (d) LC3B antibody staining shows an increased LC3B level and autophagic puncta formation in
rMC1 under HG than in LG. The pictures are representative of 3 separate experiments.
continues to accumulate under sustained hyperglycemia,
the anti-oxidant capacity is overwhelmed and an oxidative
stress occurs at day 3 to 5 when XBP1 activity is reduced.
Activation of other branches of UPR/ER stress (e.g., PERK-
eIF-2 and ATF6) is yet to be investigated. Nonetheless,
sustained ROS/RNS generation will cause excessive organelle
damage and protein aggregation leading to apoptotic signal
induction (Figure 7(b)), which may involve ER stress medi-
ated apoptotic signals, CHOP (transcription factor CEBP
homologous protein), and Bim (Bcl-2 interacting mediator
of cell death) expression [41]. Further studies are being
pursued to test this hypothesis.
Underpersistenthyperglycemia,ROS,andsustainedATP
depletion (Figure 4(b)), a hypoxic-like response in rMC1
may evoke and induce pro-inﬂammatory gene expression
for iNOS, VEGF-A, and Cox-2 as seen in Figures 7(d)–7(f).
Therefore, we measured the activity of hypoxia inducible
transcription factor (HIF) 1α in EMSA and the result
is shown in Figure 8(d). There is no increase in DNA-
binding activity of HIF-1α in rMC1 up to day 3 by HG.
However, at day 5 the HIF-1α DNA-binding activity is
enhanced, which correlates positively with the expression
of its down stream gene target, vascular permeability, and
proangiogenic VEGF-A (Figure 7(f)). These results suggest
strongly that chronic HG evokes an initially time-dependent
early innate immune and ER stress response in rMC1,
followed by ATP reduction, ROS accumulation, and HIF-1α
activation leading, at least in part, to pro-inﬂammatory and
proangiogenic gene expression.
3.7. Knockdown of TXNIP by siRNA Blocks ATP Reduction,
ROS Generation, and LC3B Activation by HG in rMC1.
Finally, we asked to what extent the sustained induction
of TXNIP in rMC1 under HG is responsible for metabolic
dysregulation in rMC1. We used a transient transfection
method of siRNA to knock down TXNIP and assess its eﬀect
on ATP and ROS levels and LC3B expression in rMC1 under
HG. First, we showed that HG-induced TXNIP protein
level is reduced by two diﬀerent TXNIP siRNAs (siTXNIP1
and siTXNIP3). As shown in Figure 9(a), siTXNIP3 gave
a consistent suppression of TXNIP. Conversely, HG is still
abletoinduceTXNIPexpressioninscrRNA-transfectedcells.
Therefore, we used the scrRNA (control) and siTXNIP3
in further studies. We observe that HG reduces ATP level
signiﬁcantly (P = 5.2E − 05, n = 6) in scrRNA-transfected
cells, which is absent in siTXNIP3-transfected rMC1 cells
(Figure 9(b)). In addition, HG-induced ROS generation
in scrRNA-transfected cells is also blocked by siTXNIP3
(Figure 9(c)). Furthermore, the staining of autophagic
marker LC3B is increased by HG in scrRNA-treated cells,
which is reduced by siTXNIP3 (Figure 9(d)). The results
demonstrate that TXNIP mediates, at least in part, cellular
oxidative stress, ATP reduction, and an autophagic response
in retinal Muller glia under chronic hyperglycemia.12 Experimental Diabetes Research
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Figure 7: HG-induced TXNIP expression correlates with proapoptotic caspase-3 expression in rMC1. (a) IHC of TXNIP. Txnip staining is
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Figure 8: HG induces an early ER stress and a later hypoxia-like response in rMC1. Messenger RNA for the spliced form of ER stress marker
XBP1 (sXBP1) was measured in rMC1 at various time periods (a) 0–24h and (b) 0–5 days after HG exposure by qRT-PCR There is no
signiﬁcant change in sXBP1 mRNA (p = ns, n = 3) when compared with respective controls at time 0. (c) The DNA-binding activity of
sXBP1 in rMC1 was further measured by EMSA using nuclear extracts (5μg) and biotin-labeled DNA probes with or without a competitive
coldDNAprobeasdescribedinMethods.Protein-DNAcomplexesweredetectedbystreptavin-HPRandECL.Inthepresenceofcompetitive
cold probe, the sXBP1 reactive band is abolished indicating the speciﬁcity of the sXBP1-DNA binding (last two lanes). Probe alone without
the nuclear extract was also run as a control (ﬁrst lane). The sXBP1 activity is increased at 4h and 1 day in rMC1 by HG and then returns
to the control level observed at day 0. (d) The DNA-binding activity of the hypoxic response factor HIF-1α in nuclear extracts was also
measured using a biotin-labeled HIF-1α binding consensus DNA probe. HIF-1α activity is not increased up to day 3 in rMC1 by HG but
enhances at day 5. Competitive cold probes block the DNA-binding of HIF-1α, indicating the speciﬁcity of the binding assay. The images are
representative of n = 3i nb o t h( c )a n d( d ) .14 Experimental Diabetes Research
(kDa)
TXNIP
TXNIP
LG HG LG HG LG HG
Actin
scrRNA siTXNIP1 siTXNIP3
rMC1, siRNA-48 h, HG-4 h
50
43
(a)
0
20000
40000
60000
80000
100000
120000
140000
160000
HG LG LG HG
R
L
U
s
/
u
g
 
p
r
o
t
e
i
n
ATP 
(ns)
Treatment, 3 days
scrRNA siTXNIP3
(P = 5.2E−05) (P = 3.2E−05,n = 6)
(b)
0
50
100
150
200
R
F
U
s
ROS
HG LG LG HG
Treatment, 3 days
scrRNA siTXNIP3
(P = 0.05 ) (ns, n = 6)
(c)
LG HG
scrRNA
siTXNIP3
LC3B (red); nuclei (blue, DAPI)
LC3B
(d)
Figure 9: TXNIP knockdown by siRNA blocks HG-mediated ATP reduction, ROS generation, and LC3B expression in rMC1. (a) Seventy to
eighty percent conﬂuent rMC1 cells were transfected transiently with an scramble siRNA (scrRNA, control) or with TXNIP mRNA-targeted
siRNAs-siTXNIP1 and siTXNIP3 (20nM each) using HiPerfect transfection reagent in six-well plates or 60mm culture plates in duplicates.
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serum) for 48h. Afterwards, HG was added for 4h and TXNIP amount was measured by Western blotting. We observe that siTXNIP3 gives
a consistent suppression of TXNIP (∼70%) and used in further studies. A representative blot of n = 4 is shown here. Actin was used as a
control for protein loading and siRNA speciﬁcity. (b) rMC1 cells were transiently transfected in 24-well plates with siTXNIP3 for 48h and
then HG was added for 72h in low serum media. Intracellular ATP concentration was measured and normalized to protein concentration
(RLUs/μg protein). HG reduces ATP level in scrRNA-treated rMC1 cells while siTXNIP3 transfection blunted HG eﬀects. (c) Similar to
ATP determination, we also measured ROS levels after 72h of HG exposure in both scrRNA and siTXNIP3-transfected rMC1 with CM-
H2DCFDA. HG increases ROS levels in scrRNA cells (P<0.05, n = 6) versus LG but this eﬀect was not observed in siTXNIP3 cells. (d)
LC3B staining under HG exposure for 5 days is also reduced in siTXNIP3-transfected cells when compared with the scrRNA cells under
similar duration of HG exposure (right panels). Under LG, LC3B staining is minimal in both scrRNA and siTXNIP3-treated rMC1 cells after
5 days. A representative of n = 3 is shown here.
4. Discussion
Muller glia plays an important function in retinal tissue
homeostasis by taking up glucose and nutrients from the
blood. It supplies metabolic products to neurons for proper
functioning and participates in uptake and detoxiﬁcation of
neurotransmitters [5, 42]. Therefore, an injury to Muller
gliaitselfandsustainedgliosiswillproduceproinﬂammatory
cytokines and proangiogenic factors that may further aﬀect
theretinalvasculatureandneuronsleadingtoocularcompli-
cationsofdiabetes[43,44].TXNIPplaysacriticalroleinreti-
nal inﬂammation and apoptosis [9, 26, 45]. Here, we provide
evidences that HG activates TXNIP in retinal Muller cells in
vitro as well as in vivo in the diabetic rat retina (this study,
[9]). We demonstrate a temporal response of Muller glia to
chronic HG exposure and programming of a series of innate
host defense mechanisms which involve (i) sustained TXNIP
up-regulation, (ii) innate immune/ER stress responses—(iii)Experimental Diabetes Research 15
ATP reduction, (iv) oxidative/nitrosative stress, (v) hypoxic-
like response, (vi) autophagy/mitophagy, (vii) inﬂammation
and, (viii) an apoptotic signal. Thus, a temporal and spatial
survival response of Muller cells to chronic hyperglycemia
emerges and TXNIP may orchestrate some of these events.
Deﬁnitely, these observations will have important implica-
tions toward understanding the molecular basis for disease
development and progression of DR and in designing stage-
speciﬁc therapeutic strategies to reduce retinal inﬂammation
and neurovascular dysfunction in diabetes.
TXNIP is considered as a pro-oxidative stress, pro-in-
ﬂammatory, and proapoptotic protein under chronic hyper-
glycemia, diabetes, and cellular stress [9, 11, 13, 26, 46].
However, these deleterious eﬀects of HG in cells are observed
at later stages of sustained hyperglycemic exposure while
TXNIP is an early response gene to HG and tissue injury.
Therefore, TXNIP may be considered as an early sensor of
metabolic and cellular danger and a signiﬁcant component
of the innate host defense mechanism(s) and wound healing
processes [10, 15, 16]. In support of this hypothesis, we
recently showed that TXNIP is responsible for S100B-RAGE
axis-induced expression of the innate immune response
mediator, pro-IL-1β, and secretion of mature IL-1β in
primary Schwann cells in culture and partial sciatic nerve
i n j u r yr e c o v e r y[ 10]. Under these conditions, an increase
in ROS generation was not observed [8, 10]. This ﬁnding
is in agreement with our current data showing that HG
induces TXNIP and pro-IL-1β expression and activation of
NLRP3 inﬂammasome and caspase-1 at 4–24h without ROS
generation (Figures 2 and 3). In fact, this is also similar
to the condition of chronic Granulomatous Disease where
impaired ROS production due to a genetic defect does not
aﬀect IL-1β secretion [47, 48].
In acute infection models using circulating monocytes
and stromal macrophages, however the NLRP3 inﬂamma-
some assembly, caspase-1 activation, and pro-IL-1β process-
ing and secretion require ROS generation and ATP release
[15, 49–51]. According to this model, during oxidative
stress, ROS dissociates TXNIP bound to TRX. TXNIP then
binds to NLRP3 to mediate NLRP3 inﬂammasome assembly
containing ASC (Apoptotic Speck Protein Containing a
Caspase Recruitment Domain (CARD)) and procaspase-1
[15, 16]. This subsequently leads to caspase-1 autocleavage
and activation. Activated caspase-1 then processes pro-IL-
1β to its mature form and is then secreted extracellularly.
IL-1β is a potent pro-inﬂammatory cytokine and, upon re-
lease, induces several pro-inﬂammatory cytokines and
chemokines. Therefore, IL-1β expression is highly regulated
at multiple steps including at least two signals—a priming
and a processing/maturation—while the mechanism of
extracellular secretion is yet to be determined [52].
In our study, pro-IL-1β, NLRP3 inﬂammasome and
procaspase-1 levels oscillate at 4h and day 3 of HG exposure.
The ﬁrst response at 4h occurs in the absence of ROS release
as discussed previously while the second response at day 3
occurs under ROS/oxidative stress. We and others [10, 21]
showed that TXNIP is responsible for pro-IL-1β priming/
expression but the role of TXNIP in NLRP3 inﬂammasome
assembly and caspase-1 activation is yet to be resolved as
conﬂicting data exist at present [15, 21, 53]. Therefore,
further studies will focus on the mechanism(s) of NLRP3
inﬂammasome activation and pro-IL-1β processing and the
roleofTXNIPinthisprocessinthediabetic retina andunder
chronic hyperglycemia.
Nutrient excess (glucose availability) leads to increase
ratesofglycolysisandenergy(ATP)production,whichisevi-
dent from our data showing elevated intracellular ATP levels
at 4h. Mitochondrial ATP synthesis produces ROS during
electron transfer and OxPhos at ETC in the mitochondrial
inner membrane. Furthermore, glucose and ATP induce
increased protein synthesis in the ER lumen and ER stress
leading to a UPR response to enhance protein folding and
anti-oxidant capacity via an induction of mitochondrial and
cytosolic superoxide dismutases and catalase [40]. Indeed,
we observed an activation of the IRE1/XBP1 pathway in
rMC1 by HG, which is demonstrated by the enhanced DNA-
binding activity of nuclear sXBP1 in EMSA (Figure 8(c)).
sXBP1 is known to activate the transcription of anti-oxidant
genes including those stated above [40]. This may partly
explain why we observed a decrease in ROS level at 4 and
24h of HG treatment in spite of TXNIP up-regulation and
IL-1β expression. Nonetheless, as hyperglycemia persists, the
sXBP1activityreducesandthedefensiveprogramisswitched
to a reduction in cellular ATP content, potentially in an
attempt to minimize mitochondrial ROS generation through
the aerobic respiration [54]. This may activate the cytosolic
anaerobic glycolysis via an inhibition of pyruvate kinase
at TCA cycle and lactate production, which is a survival
response for phagocytic and cancer cells in a hypoxic envi-
ronment during inﬂammation and tumor progression [55,
56]. Even then, the ETC in mitochondrial inner membrane
continues to leak electrons and produces ROS at complexes I
andIII[57].ThiseventuallywillleadtoaccumulationofROS
since TXNIP up-regulation can reduce the ROS scavenging
capacityofTRX.Suchaneventseemstooccuratday3ofHG
exposure in rMC1s, where there is a second surge in IL-1β
and NLRP3 expression is observed (Figure 3(d)). The surge
may be a second attempt to correct cellular metabolic defects
and induce cell survival. However, these responses cause
a further decline in cellular ATP level evoking a hypoxic-
like response (HIF-1α activation) under hyperglycemia and
normoxia (Figure 8(d)).
Sustained TXNIP up-regulation may establish an oxida-
tive stress environment in rMC1 at later stages of HG expo-
sure (Figure 4(a)) after an initial innate immune response,
ER stress, and ATP reduction. As ROS and iNOS expressions
increase at day 3, nitrosative stress and protein thiol S-
nitrosylation (SNO) as well as tyrosine nitration activities
willbeenhanced[58–60].Initially,SNOmodiﬁcationofpro-
apoptotic caspase-3 prevents its release from mitochondria
[60]; however continued ROS/RNS will damage proteins,
nucleicacids,andorganellesincludingERandmitochondria.
Therefore, another ancient survival program of autophagy
(mostlyactivatedundernutrientstarvationtorecycleprotein
aggregates and organelles) and mitophagy (removal of
damaged mitochondria by autophagic processes) is activated
[36–39]. This is supported by our observation that in
spite of the signiﬁcant increase in ROS levels (day 3 to 516 Experimental Diabetes Research
of HG), activity of mitochondrial membrane enzyme
cytochrome c oxidase at complex IV is sustained and cell
viabilityispreserved.Preservationofcellviabilityisindicated
by increased MTT that measures the reductase activity
of succinate dehydrogenase at complex II. These ﬁndings
suggest an active regeneration of mitochondria by removing
the oxidatively damaged ones and provide cell viability.
Such an assumption is supported by the observation that
autophagic LC3B punctae are increased in rMC1 (Figure 6)
and MTT activity is enhanced (Figure 5).
The mechanism of autophagy initiation is complex and
recent studies have pointed to a role of the nuclear DNA-
binding proteinHMGB1underoxidative stress[60].Nuclear
TXNIP may cause HMGB1 oxidation (S-nitrosylation) and
nuclear export [61, 62]), which participates in beclin 1 disso-
ciation from antiapoptotic bcl2 and initiation of autophagy
[38, 39]. Oxidation of HMGB1 at cysteine residues 23, 45,
and 106, probably by inhibition of TRX by TXNIP in the
nucleus, causes its translocation to the cytosol and interac-
t i o nw i t hb e c l i n1[ 38, 39]. HMGB1 is an abundant nuclear
protein considered to have a dual function: it acts (i) as
a transcriptional activator in the nucleus by binding to
linker DNA between nucleosomes inducing DNA bending
and enhances transcription factor accessibility, and (ii) as a
pro-inﬂammatory cytokine (passively or actively secreted)
by injured and dying cells as a danger signal and damage-
associatedmolecularpattern(DAMP)molecule,whichbinds
to innate pattern recognition receptors (PRRs) such as
TLR2, TLR4 and RAGE [20, 61]. (iii) In addition, HMGB1
may also have a role in autophagy in rMC1 (this study,
[60]). Previously, we showed that RAGE activation by its
endogenous ligand S100B activates TXNIP expression and
induces pro-inﬂammatory genes for IL-1β,C o x - 2 ,V E G F -
A, ICAM1, and ﬁbrotic FN [8–10]. While IL-1β is an early
mediator of innate immunity and inﬂammation, HMGB1
is regarded as a late mediator in chronic inﬂammatory
diseases [63, 64]. Thus, the HMGB1-TLR4 and/or HMGB1-
RAGE axis may further activate TXNIP and IL-1β expression
thereby potentiating a vicious cycle of innate immunity and
sterile inﬂammation under chronic hyperglycemia. The fact
thatknockdownofTXNIPbysiRNAblocksIL-1β expression
in the retina in vivo (Figure 1(c)) and ATP depletion,
ROS generation, and LC3B induction in rMC1 in vitro
(Figure 9) suggest that TXNIP is critical for Muller glia
activation, autophagy, and inﬂammation. TXNIP therefore
mayrepresentapotentgeneandtherapeutictargettoprevent
DR pathogenesis [8, 9].
Sustained ROS/RNS generation and activation of auto-
phagy/mitophagy will eventually trigger an apoptotic signal
and premature cell death due to excessive removal of
essential organelles and proteins in the cell while dam-
aged mitochondria leaks electrons [57, 58]. Mitochondrial
oxidative/nitrosative stress causes ER stress, which in turn
induces mitochondrial damage thus generating a vicious
cycle of organelle damage and tissue injury [41]. Here,
we show that increases in both TXNIP and proapoptotic
caspase-3 occur at later periods of HG exposure for example,
at day 5. Nonetheless, we propose that the ER stress and
autophagic and apoptotic signal will be shifted towards a
caspase-1/7-dependent pro-inﬂammatory cell death (pyrop-
tosis) [65]. This is because apoptosis is an ATP-dependent
(consuming) process and requires active ATP synthesis [65].
In the current study, we observe ATP depletion under
sustained HG and a late surge in caspase-1 level at day
5. Furthermore, the caspase-3 probe, FLICA, used in this
study may also recognize caspase-7, which is downstream of
caspase-1 and closely related to caspase-3. In agreement with
the idea of pyroptosis under HG, the dying and oxidatively
stressed rMC1 produces pro-inﬂammatory genes such as
TXNIP, iNOS, Cox-2, and proangiogenic VEGF-A (Figures
7(c)–7(f);[ 66]). The induction of VEGF-A is particularly
interesting because of its association with ATP depletion
and HIF-1α activation. VEGF-A is a potent vascular per-
meability and proangiogenic factor that is regulated by
HIF-1α and implicated in diabetic vasculopathy [56, 67].
Protein S-nitrosylation also consumes molecular oxygen
[58]; therefore, it may result in reduced mitochondrial ATP
production and generation of an intracellular hypoxic-like
environment inducing HIF-1α activation under normoxia.
An understanding of the TXNIP-HIF-1α-VEGF-A axis and
itstemporalresponseunderchronichyperglycemiainMuller
cells that enhances VEGF-A expression in diabetes will be
important.ItisgenerallyacceptedthatMullergliaisthemain
source of VEGF-A in the neural retina [68, 69].
An accumulation of HIF-1α in diabetic retinas of STZ-
mice was recently reported [67], which is also associated
with an increase in VEGF-A expression. Furthermore, a
disruption of the Hif-1α gene in M¨ uller cells alleviates retinal
inﬂammation and vascular leakage in diabetic Hif-1α KO
mice, further indicating an important role of M¨ uller glia-
derived HIF-1α-VEGF-A axis in DR [67]. In addition, atten-
uation of ER stress by chemical chaperones such as 4-
phenyl butaric acid reduces VEGF-A expression in retinal
endothelial cells in culture induced by hypoxia as well as in a
mouse model of oxygen-induced retinopathy (OIR) [23, 70,
71]. Thus, several reports have pointed to an important role
of ER stress/UPR signaling in retinal inﬂammation, hypoxia,
and perhaps autophagy. Nonetheless, a critical function of
TXNIP in ER stress, autophagy, and apoptosis/pyroptosis
in animal models of DR remains to be investigated, which
will form the basis for a separate manuscript. Sustained
and excessive induction of each of these cellular defen-
sive/survival processes, including ER stress and UPR, will
evoke chronic inﬂammation and DR pathogenesis. ER-
stress, autophagy, and innate immune responses are survival
mechanisms; however prolonged induction of these cellular
processeswillultimatelyleadtoprematurecelldeathanddis-
ease progression of microvascular complications of diabetes.
Cellular DAMPs (ATP, uric acid, HMGB1, mitochondrial
DNA, etc.) released by injured and dying cells are recognized
by innate PRRs such as TLR4, TLR9, RAGE, P2X7R, and
NLRP3 inﬂammasome and together the DAMPs and PRRs
may play causative roles in retinal ER-stress, autophagy,
inﬂammation, and DR pathogenesis.
Inconclusion,weshowfortheﬁrsttimethatHGsustains
TXNIP expression in rat Muller glia and orchestrates a
duration-dependent cellular program of innate host defense
and survival mechanisms that culminate in oxidative stress,Experimental Diabetes Research 17
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Figure 10: A schematic summary of potential cellular responses
by retinal Muller glia in chronic hyperglycemia and diabetes. The
sequence of molecular events that retinal Muller cells react to
chronichyperglycemiainclude(i)sustainedupregulationofTXNIP,
(ii) an initial innate immune and UPR response to excess glucose
metabolism and oxidative phosphorylation (ATP generation), (iii)
oxidative stress (ROS/RNS generation) and a hypoxia-like response
through ATP reduction, (iv) an induction of an autophagic-
mitophagic pathway, and (v) ER-stress and inﬂammation. These
cellular responses constitute intrinsic cell survival/defense mecha-
nisms, which, under chronic cell stress and injury, may promote
premature cell death and disease progression of DR.
ER stress, autophagy, inﬂammation, and cell death. While
detailed mechanisms are yet to be worked out, a temporal
pattern emerges here as to how retinal Muller glia might
respond to chronic hyperglycemia in diabetes. These include
(i) sustained TXNIP up-regulation, (ii) an initial innate
immuneandERstressresponsetoexcessglucosemetabolism
(ATP generation), (iii) oxidative stress and a hypoxia-
like response through ATP reduction, (iv) induction of
an autophagic-apoptosis pathway, and (v) inﬂammation. A
temporal response of Muller glia to chronic hyperglycemia
and potential molecular events are summarized in Figure 10.
These ﬁndings clearly point to a crucial role of TXNIP in
Muller glia activation, oxidative/nitrosative, and ER stress,
and sterile inﬂammation under chronic hyperglycemia and
suggest a potential gene and drug target for preventing
neurovascular injury/cell death and pathogenesis of DR.
Lastly,whileourmanuscriptisinsubmission,anarticlecame
out to demonstrate purinergic and glycemic induction of
TXNIP in rMC1 in culture [72], which also supports our
ﬁndings in the present study.
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